Validation StudyNCT06260800
Spanish Version of Credibility and Expectancy Questionnaire in Patients With Musculoskeletal Injuries
An observational study of Validation Study, run by University of Valladolid at 1 site in Spain.
Trial summary
Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Validation Study
- What is being tested?
- Validation CEQ
- How many people
- 76 participants
- Where
- 1 siteSpain
- Study dates
- 8 Jan 2024to 4 Dec 2024
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
Who may be able to join
- Volunteer patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
- Age above 18 years old.
- Understanding of the study purpose and signing the informed consent.
Who cannot join
- Patients with cognitive deprivation.
- Not able to fill in the questionnaires autonomously.
- Mother tongue different from Spanish.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Translation, Adaptation and Valitation of the Spanish Version of Credibility and Expectancy Questionnaire in Patiens With Musculoskeletal Injuries
Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. This relation is linked with more satisfaction and adherence during the treatment, as well as credibility and expectancy of the patient related to the treatment. Thus, Credibility and Expectancy questionnaire is normally used to assess that point. CEQ presents good psychometric properties when used in Physisiotherapy interventions, but there is not a spanish version of this questionaire.
- Conditions
- Validation Study
- Being tested
- Validation CEQ
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Validation CEQOther
In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session.
| Study group | Role | What they receive |
|---|---|---|
| CEQ Validation | In initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session. Receives: Other: Validation CEQ |
What is being measured
The primary outcome is the main question the study is designed to answer.
Content validity
Credibility and Expectancy questionnaire (CEQ) must be completed, while registering the time used and the quality and the reading comprehension.
Measured: During the intervention: Session 1
Structural validity
Exploratory factor analysis (EFA) and confirmatory factorial analysis (CFA) were performed. For EFA Kaiser criterion >0.70 will be acceptable. For CFA, goodness of fit index and comparative fit index were calculated, where values up to 0.90 were acceptable.
Measured: During the intervention: session 1 and 2 treatment
Reliability
Credibility and Expectancy questionnaire (CEQ) reliability will be analised through internal consistency (alpha Cronbach > 0.70 recomended)) and test-retest (intraclass correlation coeficient >0.70 acceptable).
Measured: During the intervention.
Hypotheses testing for construct validity
Comparing CEQ with other measurement instruments.
Measured: During the intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted15 Feb 2024
- Study start8 Jan 2024
- Primary completion15 Jul 2024
- Study completion4 Dec 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Validation StudyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 76 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Valladolid
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Silvia Lahuerta Martín, University of Valladolid
- Investigators
- Silvia Lahuerta Martín, Principal investigator, University of Valladolid, Soria, Spain
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06260800
- Sponsor's protocol ID
- PI 23-3405
- Status last verified
- Dec 2024
- First submitted
- 18 Dec 2023
- Last updated
- 31 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Translation, Adaptation and Valitation of the Spanish Version of Credibility and Expectancy Questionnaire in Patiens With Musculoskeletal Injuries
- ClinicalTrials.gov ID
- NCT06260800
- Acronym / sponsor ID
- PI 23-3405
- Conditions
- Validation Study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 76 participants (actual)
- Lead sponsor
- University of ValladolidUniversity, hospital or other
- Study start
- 8 Jan 2024 (actual)
- Primary completion
- 15 Jul 2024 (actual)
- Study completion
- 4 Dec 2024 (actual)
- First posted
- 15 Feb 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Physiotherapy treatment of musculoskeletal injuries should be performed following the main clinical guidelines of person-centered care. Patients' perception of the abilities and facilities provided by physiotherapists boost a convenient therapeutic relationship. This relation is linked with more satisfaction and adherence during the treatment, as well as credibility and expectancy of the patient related to the treatment. Thus, Credibility and Expectancy questionnaire is normally used to assess that point. CEQ presents good psychometric properties when used in Physisiotherapy interventions, but there is not a spanish version of this questionaire.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| CEQ Validation | – | Other: Validation CEQIn initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
Key inclusion criteria (3 listed)
- Volunteer patients who are going to start physiotherapy treatment due to musculoskeletal injuries.
- Age above 18 years old.
- Understanding of the study purpose and signing the informed consent.
Key exclusion criteria (3 listed)
- Patients with cognitive deprivation.
- Not able to fill in the questionnaires autonomously.
- Mother tongue different from Spanish.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Validation CEQIn initial assessment, EQ-5D-5L and HADS questionnaires were completed. After sessions 1 and 2, CEQ and WAI-S were filled. Finally, EQ-5D-5L was completed before the fourth session. | Other | CEQ Validation |
Primary outcome
Content validity
Time frame: During the intervention: Session 1
Credibility and Expectancy questionnaire (CEQ) must be completed, while registering the time used and the quality and the reading comprehension.
Structural validity
Time frame: During the intervention: session 1 and 2 treatment
Exploratory factor analysis (EFA) and confirmatory factorial analysis (CFA) were performed. For EFA Kaiser criterion >0.70 will be acceptable. For CFA, goodness of fit index and comparative fit index were calculated, where values up to 0.90 were acceptable.
Reliability
Time frame: During the intervention.
Credibility and Expectancy questionnaire (CEQ) reliability will be analised through internal consistency (alpha Cronbach > 0.70 recomended)) and test-retest (intraclass correlation coeficient >0.70 acceptable).
Hypotheses testing for construct validity
Time frame: During the intervention.
Comparing CEQ with other measurement instruments.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Dec 2025.
- Individual participant dataSharing planned: No
Related trials for Validation Study
Not yet recruitingObservational study
Validation of the Healthcare Relationship Assessment Scale (ERA) in Health Sciences Students.
Health Adult Subjects, Communication
RecruitingObservational study
Development and Validation of a Multimodal Deep Learning Model Using Peripheral Oxygen Saturation and Ballistocardiography Signals for Predicting Apnea-Hypopnea Index in Obstructive Sleep Apnea
Obstructive Sleep Apnea
Active, not recruitingPhase 1
Prospective Exploratory Study of FAPi PET/CT With Histopathology Validation in Patients With Various Cancers
Bladder Carcinoma, Cervical Carcinoma
RecruitingObservational study
Validity and Reliability of the 2-Minute Step Test in Patients With Lipedema
Lipedema
Not yet recruitingObservational study
AI-Assisted Differentiation of Pancreatic Cystic Lesions Using EUS Images and Clinical Features
Pancreatic Mucinous Cystic Neoplasm, Pancreatic Serous Cystic Neoplasm
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Silvia Lahuerta Martín principal investigator
University of Valladolid, Soria, Spain
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Validation Study, run by University of Valladolid at 1 site in Spain.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 31 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Content validity (time frame: During the intervention: Session 1). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Dec 2025.